Target intelligence / Profile preview

Mediator complex subunit 1 (MED1)

Target
MED1
Molecular classification
Transcription coactivator, Mediator complex subunit, Nuclear receptor coactivator, Other (component of multisubunit transcription complexes)
01

Overview

Mediator complex subunit 1 (MED1) is a central component of the Mediator complex, a multiprotein assembly that serves as a bridge between gene-specific regulatory proteins—especially nuclear hormone receptors—and the general RNA polymerase II transcription machinery[7][6][2]. MED1 directly binds and coactivates a diverse range of transcription factors, including nuclear receptors (such as estrogen receptor, peroxisome proliferator-activated receptor gamma, and thyroid hormone receptor), master developmental regulators (such as GATA-1), and tumor suppressors (such as p53), to modulate gene transcription[7][2][4][5]. MED1 displays critical roles in cell fate determination, proliferation, differentiation, and apoptosis; it is indispensable in mammalian development, as its genetic deficiency leads to embryonic lethality with developmental defects[4]. MED1 also acts as a key regulator of DNA damage response by partnering with BRCA1 and supporting homologous recombination repair[3]. Overexpression or deregulation of MED1 is implicated in cancer, including as a negative prognostic marker in breast tumors, where it enhances proliferation, migration, and endocrine response through interactions with ER-alpha and specific microRNAs[1]. Its broad and essential functions render it a challenging but potentially valuable target in malignancies driven by dysregulated nuclear receptor signaling or transcriptional control.

Other names
Mediator of RNA polymerase II transcription subunit 1ARC205CRSP1CRSP200DRIP205DRIP230PBPPPARBPPPARGBPRB18ATRAP220TRIP2Peroxisome proliferator-activated receptor-binding proteinThyroid hormone receptor-associated protein complex 220 kDa componentThyroid receptor-interacting protein 2Vitamin D receptor-interacting protein complex component DRIP205p53 regulatory protein RB18AActivator-recruced cofactor 205 kDa component
02

Mechanism of action

Modulation of gene expression via coactivation of nuclear receptors (e.g., estrogen receptor, peroxisome proliferator-activated receptor gamma, thyroid hormone receptor) Regulation of transcriptional complexes involving tumor suppressors (e.g., p53), hormone receptors, and DNA repair proteins (e.g., BRCA1)

03

Biological functions

Transcriptional regulationNuclear receptor coactivationCell proliferationCell differentiationApoptosisDNA repair (homologous recombination)Signal transduction
04

Disease associations

CancerDevelopmental disordersHematopoietic defectsBreast cancerPotential role in other hormone-dependent cancersDNA damage-related diseases
05

Safety considerations

Potential risk for off-target modulation of global transcription if therapeutically targetedBroad involvement in essential cellular pathways—cell cycle, differentiation, DNA repair—implies risk of cytotoxicity or developmental toxicity
06

Biomarkers

Overexpression linked with poor prognosis in breast cancer[1]Inducer/partner for gene expression profiles in ER-positive tumors

Beyond the preview

Go deeper on Mediator complex subunit 1 (MED1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator complex subunit 1 (MED1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call